Diagnosis and treatment of a typical and anaplastic meningiomas: A review

被引:242
作者
Modha, A
Gutin, PH
机构
[1] Mem Sloan Kettering Canc Ctr, Neurol Serv, New York, NY 10021 USA
[2] Cornell Univ, Dept Neurol Surg, Weill Med Coll, New York, NY USA
关键词
atypical meningiomas; anaplastic meningiomas; stereotactic radiosurgery; brachytherapy;
D O I
10.1227/01.NEU.0000170980.47582.A5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
ATYPICAL AND ANAPLASTIC meningiomas are uncommon tumors with a poorer prognosis than benign meningiomas. We reviewed the current literature and attempted to integrate and summarize available information to determine a logical approach to these tumors. Both tumors are rare and are often integrated with benign meningiomas when treatments are evaluated. In addition, because there has not been one histopathological classification scheme for atypical and anaplastic meningiomas in the past, there are numerous inconsistencies in the literature. Malignant progression with accumulation of mutations in a benign meningioma can result in an atypical and/or anaplastic meningioma. Both tumors are difficult to manage and have high recurrence and poor survival rates. The extent of tumor resection and histological grade are the key determinants for recurrence. In addition, metastases are unusual, but they do occur. We also review the evidence available that has resulted in the current World Health Organization classification. Radiation therapy can be used as an adjunctive treatment after both total and subtotal resection. In addition, the role of stereotactic radiosurgery is increasing, along with a possible role for brachytherapy. There are no effective chemotherapeutic agents available. A treatment algorithm is suggested.
引用
收藏
页码:538 / 549
页数:12
相关论文
共 68 条
[21]   The treatment of recurrent unresectable and malignant meningiomas with interferon alpha-2B [J].
Kaba, SE ;
DeMonte, F ;
Bruner, JM ;
Kyritsis, AP ;
Jaeckle, KA ;
Levin, V ;
Yung, WKA .
NEUROSURGERY, 1997, 40 (02) :271-275
[22]   Hemorrhagic complications in embolization of a meningioma: Case report and review of the literature [J].
Kallmes, DF ;
Evans, AJ ;
Kaptain, GJ ;
Mathis, JM ;
Jensen, ME ;
Jane, JA ;
Dion, JE .
NEURORADIOLOGY, 1997, 39 (12) :877-880
[23]   Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas [J].
Karamitopoulou, E ;
Perentes, E ;
Tolnay, M ;
Probst, A .
HUMAN PATHOLOGY, 1998, 29 (02) :140-145
[24]  
Kleihues P., 2000, PATHOLOGY GENETICS T
[25]   Long-term outcomes after meningioma radiosurgery: physician and patient perspectives [J].
Kondziolka, D ;
Levy, EI ;
Niranjan, A ;
Flickinger, JC ;
Lunsford, LD .
JOURNAL OF NEUROSURGERY, 1999, 91 (01) :44-50
[26]   Meningioma pathology, genetics, and biology [J].
Lamszus, K .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2004, 63 (04) :275-286
[27]  
Lamszus K, 2000, NEUROSURGERY, V46, P938
[28]   Non-resectable slow-growing meningiomas treated by hydroxyurea [J].
Loven, D ;
Hardoff, R ;
Bar Sever, Z ;
Steinmetz, AP ;
Gornish, M ;
Rappaport, ZH ;
Fenig, E ;
Ram, Z ;
Sulkes, A .
JOURNAL OF NEURO-ONCOLOGY, 2004, 67 (1-2) :221-226
[29]   ATYPICAL AND MALIGNANT MENINGIOMAS - A CLINICOPATHOLOGICAL REVIEW [J].
MAHMOOD, A ;
CACCAMO, DV ;
TOMECEK, FJ ;
MALIK, GM ;
BLACK, PM ;
KEPES, J .
NEUROSURGERY, 1993, 33 (06) :955-963
[30]   CLASSIC, ATYPICAL, AND ANAPLASTIC MENINGIOMA - 3 HISTOPATHOLOGICAL SUBTYPES OF CLINICAL RELEVANCE [J].
MAIER, H ;
OFNER, D ;
HITTMAIR, A ;
KITZ, K ;
BUDKA, H .
JOURNAL OF NEUROSURGERY, 1992, 77 (04) :616-623